Implantation of stents into significant carotid artery stenoses using the FilterWire EZ<sup>TM</sup> system
Josef Veselka(Universitat Autònoma de Barcelona), Martin Šrámek(Charles University), Petr Hájek(University Hospital in Motol), Petra Zimolová(University Hospital in Motol), Radka Adlová(Charles University), Martin Malý(Charles University), David Tesař(Charles University), Jiří Fiedler(Charles University), Pavel Stanka(University Hospital in Motol), Lucie Martinkovičová(Charles University), Aleš Tomek(Charles University), Daniela Černá(University Hospital in Motol), David Zemánek
Cited by 2
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population
|European Heart Journal|2014|106
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65